PHK
TNXP icon

Point72 Hong Kong’s Tonix Pharmaceuticals TNXP Stock Holding History

Point72 Hong Kong’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Hold
0
– -$10K – 2405
2022
Q1 		– Sell
-1
Closed -$153K – 1610
2021
Q4 		$125K Buy
+1
New +$318K ﹤0.01% 1126
2021
Q3 		– Hold
0
– – – 1832

Other funds holding TNXP

M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Hong Kong's TNXP Position: Q2 2022 in Review

Point72 Hong Kong held its Tonix Pharmaceuticals (TNXP) position steady in Q2 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2405.

Point72 Hong Kong first reported a position in TNXP in Q4 2021 and has held it in 1 quarter since. The position peaked at $125K in Q4 2021. 23 funds tracked by Wall St. Rank hold TNXP as of Q2 2022.

  • Point72 Hong Kong held 0 shares of Tonix Pharmaceuticals worth $0 as of Q2 2022.
  • Point72 Hong Kong left its Tonix Pharmaceuticals share count unchanged in Q2 2022.
  • Tonix Pharmaceuticals made up ﹤0.01% of Point72 Hong Kong's portfolio in Q2 2022, its #2405 holding.
  • Point72 Hong Kong first reported a position in Tonix Pharmaceuticals in Q4 2021 and has held it in 1 quarter since.
  • Point72 Hong Kong's Tonix Pharmaceuticals position peaked at $125K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.